Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
10981 participants
OBSERVATIONAL
2003-08-31
2016-09-27
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Completion Notice: The ISPR was created by Medtronic to monitor the performance of commercially available products. This registry was initially designed to track performance of Medtronic's implantable infusion and spinal cord stimulation systems beginning in August 2003 and June 2004, respectively. Medtronic DBS Systems were added to the ISPR in June 2009, and Sacral Neuromodulation Systems in April 2010. Medtronic retired the ISPR in April 2016 and merged the data collected from this registry into the Product Surveillance Registry (PSR). Please refer to that record, Clinical Trials identifier: NCT01524276, for further information.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Streamlined Denervation With spYral For an Optimized Treatment (SPYRAL SWYFT) in Subjects With Uncontrolled Hypertension
NCT07115953
Spyral InSight Study
NCT07013929
Implantable System for Remodulin Post-Approval Study
NCT03833323
International Ledless Pacemaker Registry
NCT05528029
Respicardia, Inc. Pivotal Trial of the remedē System
NCT01816776
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients with a device implant
Patients implanted and consented at a study center with a market-released Medtronic implantable drug pump, spinal cord stimulator, deep brain stimulator, or sacral nerve stimulator.
Various
Patients implanted and consented at a study center with a market-released Medtronic implantable drug pump, spinal cord stimulator, deep brain stimulator, or sacral nerve stimulator.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Various
Patients implanted and consented at a study center with a market-released Medtronic implantable drug pump, spinal cord stimulator, deep brain stimulator, or sacral nerve stimulator.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Patient is currently enrolled in or plans to enroll in any concurrent drug and/or device study that may confound the results of this study
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
MedtronicNeuro
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
ISPR Team
Role: STUDY_CHAIR
Medtronic
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Huntsville, Alabama, United States
Scottsdale, Arizona, United States
Aliso Viejo, California, United States
Los Angeles, California, United States
Napa, California, United States
Palm Springs, California, United States
Pasadena, California, United States
San Diego, California, United States
Upland, California, United States
Washington D.C., District of Columbia, United States
Site recruiting for sacral nerve stimulation
Bradenton, Florida, United States
Merritt Island, Florida, United States
Ocala, Florida, United States
Atlanta, Georgia, United States
Gainesville, Georgia, United States
Bloomington, Illinois, United States
Chicago, Illinois, United States
Evansville, Indiana, United States
Muncie, Indiana, United States
South Bend, Indiana, United States
Iowa City, Iowa, United States
West Des Moines, Iowa, United States
Annapolis, Maryland, United States
Silver Spring, Maryland, United States
Westminster, Maryland, United States
Minneapolis, Minnesota, United States
Saint Paul, Minnesota, United States
St Louis, Missouri, United States
Buffalo, New York, United States
Great Neck, New York, United States
New York, New York, United States
Poughkeepsie, New York, United States
Winston-Salem, North Carolina, United States
Site is recruiting for Deep Brain Stimulation
Cincinnati, Ohio, United States
West Chester, Ohio, United States
York, Pennsylvania, United States
Nashville, Tennessee, United States
Houston, Texas, United States
Tyler, Texas, United States
Salt Lake City, Utah, United States
Roanoke, Virginia, United States
Bremerton, Washington, United States
Seattle, Washington, United States
Vienna, , Austria
Montpellier, , France
Cologne, , Germany
Hanover, , Germany
Pavia, , Italy
Barcelona, , Spain
Oxford, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NSP0010-10000
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.